Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00397358
Recruitment Status :
(Lack of enrollment)
This prospective, open label, multi-center study evaluates the use of 7.5% icodextrin used in the long-dwell exchange in peritoneal dialysis patients with elevated triglyceride levels. Fasting triglyceride levels will be measured during the study.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
written informed consent
CAPD/APD on dialysis for at least 3 months
Elevated fasting triglyceride levels
enrolled in another study requiring IRB approval
allergy to starch-based polymers
glycogen storage disease
maltose or isomaltose intolerance
active alcohol/substance abuse
Pregnant or nursing
received an investigational drug within 30 days of screening